Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER-2-positive breast cancer.
Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER-2-positive breast cancer.
复制标题
ER 和 HER2 蛋白的共表达类型作为确定 ER 阳性和 HER-2 阳性乳腺癌患者抗雌激素治疗耐药性的预测因素。
DOI：
--
复制
发表时间：
2005
期刊：
影响因子：
--
通讯作者：
Morishita Y
中科院分区：
文献类型：
--
作者：
Horiguchi J;Koibuchi Y;Iijima K;Yoshida T;Takata D;Rokutanda N;Nagaoka R;Oyama T;Iino Y;Morishita Y
